Synthesis and in vitro antitumoral activity of new 3,5-dicyanopyridine derivatives Original Research Article

A new series of 2-amino-4-aryl-6-dialkylamino-3,5-dicyanopyridines, 20–47, were synthesized in satisfactory overall yield, through a simple synthetic strategy using 3-amino-3-(dialkylamino)-propenenitriles 1 and 2 as key intermediates. 3,5-Dicyanopyridine derivatives 20–47 were evaluated for their in vitro anticancer activity toward cell lines of nine different types of human cancers. Some of the newly prepared compounds demonstrated inhibitory effects on the growth of a wide range of cancer cell lines generally at 10−6 M level and in some cases at 10−8 M concentration.